Incomplete penetrance of NRXN1 deletions in families with schizophrenia

Schizophrenia Research

Volumn 155, Issue 1-3, 2014, Pages 1-7

  Todarello, Giovanna ^a   Feng, Ningping ^b   Kolachana, Bhaskar S ^b   Li, Chao ^c   Vakkalanka, Radhakrishna ^b   Bertolino, Alessandro ^c,d   Weinberger, Daniel R ^b,c,e   Straub, Richard E ^c  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CNV; Copy number variation; Deletion; Neurexin; NRXN1; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; FAMILY STUDY; FEMALE; GENE; GENE DELETION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; NRXN1 GENE; PENETRANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; YOUNG ADULT;

NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; NRXN1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; CELL ADHESION MOLECULES, NEURONAL; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PENETRANCE; SCHIZOPHRENIA; SEQUENCE DELETION; YOUNG ADULT;

EID: 84899482715     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.02.023     Document Type: Article

References (27)

1. Bassett A.S., Chow E.W., Weksberg R. Chromosomal abnormalities and schizophrenia. Am. J. Med. Genet. 2000, 97(1):45-51.
2. Bena F., Bruno D.L., Eriksson M., van Ravenswaaij-Arts C., Stark Z., Dijkhuizen T., Gerkes E., Gimelli S., Ganesamoorthy D., Thuresson A.C., Labalme A., Till M., Bilan F., Pasquier L., Kitzis A., Dubourgm C., Rossi M., Bottani A., Gagnebin M., Sanlaville D., Gilbert-Dussardier B., Guipponi M., van Haeringen A., Kriek M., Ruivenkamp C., Antonarakis S.E., Anderlid B.M., Slater H.R., Schoumans J. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Am. J. Med. Genet. 2013, 162B:388-403.
3. Cardno A.G., Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 2000, 97(1):12-17.
4. Ching M.S., Shen Y., Tan W.H., Jeste S.S., Morrow E.M., Chen X., Mukaddes N.M., Yoo S.Y., Hanson E., Hundley R., Austin C., Becker R.E., Berry G.T., Driscoll K., Engle E.C., Friedman S., Gusella J.F., Hisama F.M., Irons M.B., Lafiosca T., LeClair E., Miller D.T., Neessen M., Picker J.D., Rappaport L., Rooney C.M., Sarco D.P., Stoler J.M., Walsh C.A., Wolff R.R., Zhang T., Nasir R.H., Wu B.L., Children's Hospital Boston Genotype Phenotype Study, G. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am. J. Med. Genet. 2010, 153B(4):937-947.
5. Colella S., Yau C., Taylor J.M., Mirza G., Butler H., Clouston P., Bassett A.S., Seller A., Holmes C.C., Ragoussis J. QuantiSNP: an objective Bayes hidden-Markov model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res. 2007, 35(6):2013-2025.
6. Dabell M.P., Rosenfeld J.A., Bader P., Escobar L.F., El-Khechen D., Vallee S.E., Dinulos M.B., Curry C., Fisher J., Tervo R., Hannibal M.C., Siefkas K., Wyatt P.R., Hughes L., Smith R., Ellingwood S., Lacassie Y., Stroud T., Farrell S.A., Sanchez-Lara P.A., Randolph L.M., Niyazov D., Stevens C.A., Schoonveld C., Skidmore D., Mackay S., Miles J.H., Moodley M., Huillet A., Neill N.J., Ellison J.W., Ballif B.C., Shaffer L.G. Investigation of NRXN1 deletions: clinical and molecular characterization. Am. J. Med. Genet. 2013, 161(4):717-731.
7. Dickinson D., Goldberg T.E., Gold J.M., Elvevag B., Weinberger D.R. Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophr. Bull. 2011, 37(6):1157-1167.
8. Doherty J.L., O'Donovan M.C., Owen M.J. Recent genomic advances in schizophrenia. Clin. Genet. 2012, 81(2):103-109.
9. Duong L., Klitten L.L., Moller R.S., Ingason A., Jakobsen K.D., Skjodt C., Didriksen M., Hjalgrim H., Werge T., Tommerup N. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders. Am. J. Med. Genet. 2012, 159B(3):354-358.
10. Egan M.F., Goldberg T.E., Gscheidle T., Weirich M., Bigelow L.B., Weinberger D.R. Relative risk of attention deficits in siblings of patients with schizophrenia. Am. J. Psychiatry 2000, 157(8):1309-1316.
11. Gottesman I. Schizophrenia Genesis: The Origins of Madness 1991, Henry Holt & Company, New York, N.Y.
12. Grozeva D., Conrad D.F., Barnes C.P., Hurles M., Owen M.J., O'Donovan M.C., Craddock N., Kirov G., WTCCC Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr. Res. 2012, 135(1-3):1-7.
13. Huang W., Richards S., Carbone M.A., Zhu D., Anholt R.R., Ayroles J.F., Duncan L., Jordan K.W., Lawrence F., Magwire M.M., Warner C.B., Blankenburg K., Han Y., Javaid M., Jayaseelan J., Jhangiani S.N., Muzny D., Ongeri F., Perales L., Wu Y.Q., Zhang Y., Zou X., Stone E.A., Gibbs R.A., Mackay T.F. Epistasis dominates the genetic architecture of Drosophila quantitative traits. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(39):15553-15559.
14. Kirov G., Gumus D., Chen W., Norton N., Georgieva L., Sari M., O'Donovan M.C., Erdogan F., Owen M.J., Ropers H.H., Ullmann R. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 2008, 17(3):458-465.
15. Kirov G., Rujescu D., Ingason A., Collier D.A., O'Donovan M.C., Owen M.J. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr. Bull. 2009, 35(5):851-854.
16. Kirov G., Rees E., Walters J.T., Escott-Price V., Georgieva L., Richards A.L., Chambert K.D., Davies G., Legge S.E., Moran J.L., McCarroll S.A., O'Donovan M.C., Owen M.J. The penetrance of copy number variations for schizophrenia and developmental delay. Biol. Psychiatry 2014, 75(5):378-385.
17. Levinson D.F., Shi J., Wang K., Oh S., Riley B., Pulver A.E., Wildenauer D.B., Laurent C., Mowry B.J., Gejman P.V., Owen M.J., Kendler K.S., Nestadt G., Schwab S.G., Mallet J., Nertney D., Sanders A.R., Williams N.M., Wormley B., Lasseter V.K., Albus M., Godard-Bauche S., Alexander M., Duan J., O'Donovan M.C., Walsh D., O'Neill A., Papadimitriou G.N., Dikeos D., Maier W., Lerer B., Campion D., Cohen D., Jay M., Fanous A., Eichhammer P., Silverman J.M., Norton N., Zhang N., Hakonarson H., Gao C., Citri A., Hansen M., Ripke S., Dudbridge F., Holmans P.A., The Schizophrenia Psychiatric G.C. Genome-wide association study of multiplex schizophrenia pedigrees. Am. J. Psychiatry 2012, 169(9):963-973.
18. MacIntyre D.J., Blackwood D.H., Porteous D.J., Pickard B.S., Muir W.J. Chromosomal abnormalities and mental illness. Mol. Psychiatry 2003, 8(3):275-287.
19. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148(6):1223-1241.
20. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
21. Rees E., Walters J.T., Georgieva L., Isles A.R., Chambert K.D., Richards A.L., Mahoney-Davies G., Legge S.E., Moran J.L., McCarroll S.A., O'Donovan M.C., Owen M.J., Kirov G. Analysis of copy number variations at 15 schizophrenia-associated loci. Br. J. Psychiatry 2014, 204:108-114.
22. Rujescu D., Ingason A., Cichon S., Pietilainen O.P., Barnes M.R., Toulopoulou T., Picchioni M., Vassos E., Ettinger U., Bramon E., Murray R., Ruggeri M., Tosato S., Bonetto C., Steinberg S., Sigurdsson E., Sigmundsson T., Petursson H., Gylfason A., Olason P.I., Hardarsson G., Jonsdottir G.A., Gustafsson O., Fossdal R., Giegling I., Moller H.J., Hartmann A.M., Hoffmann P., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Djurovic S., Melle I., Andreassen O.A., Hansen T., Werge T., Kiemeney L.A., Franke B., Veltman J., Buizer-Voskamp J.E., Investigators G., Sabatti C., Ophoff R.A., Rietschel M., Nothen M.M., Stefansson K., Peltonen L., St Clair D., Stefansson H., Collier D.A. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 2009, 18(5):988-996.
23. Schaaf C.P., Boone P.M., Sampath S., Williams C., Bader P.I., Mueller J.M., Shchelochkov O.A., Brown C.W., Crawford H.P., Phalen J.A., Tartaglia N.R., Evans P., Campbell W.M., Chun-Hui Tsai A., Parsley L., Grayson S.W., Scheuerle A., Luzzi C.D., Thomas S.K., Eng P.A., Kang S.H., Patel A., Stankiewicz P., Cheung S.W. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions. Eur. J. Hum. Genet. 2012, 20:1240-1247.
24. Spielmann M., Klopocki E. CNVs of noncoding cis-regulatory elements in human disease. Curr. Opin. Genet. Dev. 2013, 23(3):249-256.
25. Vassos E., Collier D.A., Holden S., Patch C., Rujescu D., St Clair D., Lewis C.M. Penetrance for copy number variants associated with schizophrenia. Hum. Mol. Genet. 2010, 19(17):3477-3481.
26. Wang K., Li M., Hadley D., Liu R., Glessner J., Grant S.F., Hakonarson H., Bucan M. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007, 17(11):1665-1674.
27. Wray N.R., Gottesman I.I. Using summary data from the Danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front. Genet. 2012, 3(Article 118):1-12.